Since society rebounded from the pandemic, Teladoc Health has gone from a soaring rocket ship held up by many as an emblem of the potential of tech in health care to a cautionary tale about overblown hype. Its telehealth services are now viewed by many as an interchangeable commodity in a crowded market.
In his first prominent public appearance as CEO of the virtual care giant, Chuck Divita showed up and played the part — promising growth and stability, and reminding investors of the company’s strong foundation.
“I think it’s maybe under-appreciated is just the scale and breadth of what this company has been able to commercialize,” Divita told investors on the stage in a coveted slot on the first day of the J.P. Morgan Health Care conference in San Francisco. “There’s not many things in health care that can tout 93 million lives of anything,” he said referring to the number of people eligible for Teladoc’s medical services through employers and health plans.
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in